InvestorsHub Logo
icon url

Prince Mishkin

04/26/10 8:14 PM

#1686 RE: OneCherAtatime #1685

If you ask me, Positron is in a situation where they will need to be bought out in order to stay 'in business'. Even if not positron anymore, it allows them to keep working. That said, they also have a unique product with a corner on a niche market.

All of this (considering it is true) means that a large biomed corporation would be silly not to pick up POSC and it's technology for what would technically be cheap.

If you have Level 2 sources, watch for the large block buys without sellbacks. Look for the selling volume to get smaller and we will see prices go up.


-PM

Take it at face value, do your due dilligence, the usual stuff...
icon url

BroncoBill

04/26/10 8:17 PM

#1687 RE: OneCherAtatime #1685

The word "initiatives" was too bland for the market...

And by market, I mean scummy day traders and investor newbies. If you can construe the next blurb from BMR, which said "partnership" as a buyout op....and I have little reason to suspect it isn't, then we are still on target for a heckuva profit. If they announce some crap on May 5th that is equally ambiguous, you can kiss this one goodbye.

I don't see them spending that kind of coin on the Nasdaq MarketSite for anything less than a story that will shatter upper resistance. Plus, BMR has too much reputation to lose on a junk PR release.
icon url

azbowhunter1222

04/26/10 8:26 PM

#1688 RE: OneCherAtatime #1685

That partnership and buyout are one in the same. make sense for the big Company to just purchase POSC. Why fool around with a partnership. jmho



I share that opinion 100%